Vaš brskalnik ne omogoča JavaScript!
JavaScript je nujen za pravilno delovanje teh spletnih strani. Omogočite JavaScript ali pa uporabite sodobnejši brskalnik.
Repozitorij Univerze v Ljubljani
Nacionalni portal odprte znanosti
Odprta znanost
DiKUL
slv
|
eng
Iskanje
Napredno
Novo v RUL
Kaj je RUL
V številkah
Pomoč
Prijava
Podrobno
Cross-species upregulation of MAGED2 in liver cancer suggests a role in obesity-driven tumor progression
ID
Bayat, Tara
(
Avtor
),
ID
Blagotinšek Cokan, Kaja
(
Avtor
),
ID
Rozman, Damjana
(
Avtor
),
ID
Fon Tacer, Klementina
(
Avtor
), et al.
PDF - Predstavitvena datoteka,
prenos
(3,09 MB)
MD5: E94D0D6233D13ABC9279BF34033EB321
URL - Izvorni URL, za dostop obiščite
https://www.mdpi.com/1467-3045/48/2/139
Galerija slik
Izvleček
Melanoma-associated antigens (MAGEs) are cancer-testis antigens (CTAs) aberrantly expressed in multiple cancer types, including hepatocellular carcinoma (HCC), and associated with aggressive phenotypes. Although MAGE proteins are widely studied as cancer immunotherapy targets, their roles in HCC and the regulation of their expression during liver pathogenesis in mouse models, including dietary effects, remain poorly understood. We analyzed Mage gene expression in liver tissues from 78 C3H/HeJ mice with chronic diet-induced obesity. While type I MAGE genes are frequently expressed in human HCC, we found no evidence of their expression in mouse liver tumors, suggesting species-specific regulation. In contrast, type II Maged2, previously reported to be upregulated in human HCC, was significantly increased in mouse liver tumors. Analysis of human HCC samples from The Cancer Genome Atlas (TCGA) database confirmed MAGED2 upregulation and its association with patient prognosis. Together, these findings identify MAGED2 as a conserved marker of liver cancer in both humans and mice and emphasize the importance of cross-species comparative approaches for selecting appropriate models and accurately interpreting results, particularly for CTAs, which often evolved recently and in a species-specific manner.
Jezik:
Angleški jezik
Ključne besede:
cancer-testis antigen
,
CTA
,
comparative cancer research
,
hepatocellular carcinoma
,
high-fat diet
,
liver tumors
,
melanoma-associated antigen
,
MAGE
,
obesity
Vrsta gradiva:
Članek v reviji
Tipologija:
1.01 - Izvirni znanstveni članek
Organizacija:
MF - Medicinska fakulteta
Status publikacije:
Objavljeno
Različica publikacije:
Objavljena publikacija
Leto izida:
2026
Št. strani:
23 str.
Številčenje:
Vol. 48, iss. 2, art. 139
PID:
20.500.12556/RUL-182429
UDK:
616.36-006:613.25
ISSN pri članku:
1467-3045
DOI:
10.3390/cimb48020139
COBISS.SI-ID:
277413635
Datum objave v RUL:
11.05.2026
Število ogledov:
142
Število prenosov:
137
Metapodatki:
Citiraj gradivo
Navadno besedilo
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Kopiraj citat
Objavi na:
Gradivo je del revije
Naslov:
Current issues in molecular biology
Skrajšan naslov:
Curr. issues mol. biol.
Založnik:
MDPI
ISSN:
1467-3045
COBISS.SI-ID:
521769497
Licence
Licenca:
CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:
http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:
To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.
Sekundarni jezik
Jezik:
Slovenski jezik
Ključne besede:
antigen raka testisov
,
CTA
,
primerjalne raziskave raka
,
hepatocelularni karcinom
,
prehrana z visoko vsebnostjo maščob
,
tumorji jeter
,
z melanomom povezan antigen
,
MAGE
,
debelost
Projekti
Financer:
ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:
P1-0390
Naslov:
Funkcijska genomika in biotehnologija za zdravje
Financer:
Empirical Foods Inc.
Številka projekta:
A18-0187
Financer:
TTUAB
Program financ.:
Grants-in-Aid
Financer:
Cancer Prevention and Research Institute of Texas
Številka projekta:
RR200059
Financer:
Texas Tech University
Program financ.:
Start-up
Financer:
Texas Tech University, School of Veterinary Medicine
Program financ.:
Seed award
Financer:
TC3R - Texas Center for Comparative Cancer Research
Financer:
Foundation for Prader–Willi Syndrome Research
Številka projekta:
22-0321
Financer:
Foundation for Prader–Willi Syndrome Research
Številka projekta:
23-0447
Podobna dela
Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:
Nazaj